We are proud to announce the appointment of our very own, Frank Harris, IV, to Vice President of Healthcare Technology. Frank, who has been a valuable member of our team since April 2021, has consistently exemplified our core values. His exceptional leadership, mentorship, and a dedication to excellence have been truly remarkable. We are looking forward to the positive impact he will have on Crosstree. Congratulations Frank! #investmentbanking #lifesciences #bankingcareers #banking
Crosstree
Investment Banking
Tampa, FL 9,364 followers
Crosstree is a global leader in health sciences M&A and Financing Advisory.
About us
Crosstree is a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the life sciences and healthcare industries: pharmaceutical services, diagnostics and tools, and digital health. Since 2004, Crosstree has advised on more completed transactions in these collective subsectors than any other investment bank. The firm provides clients a full suite of advisory and capital raising services, including both buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstree's narrow industry focus provides clients the expertise common of a bulge-bracket investment banking firm to middle-market companies and investors, with unparalleled industry insights, well-established strategic relationships across the globe and superior access to capital markets. From our offices in Tampa, Florida, Crosstree has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion. All securities transactions are offered by and conducted through Crosstree Capital Securities, LLC, a broker-dealer registered with the SEC, a member of FINRA (www.finra.org) and SIPC (www.sipc.org), and an affiliate of Crosstree Capital Partners, Inc.
- Website
-
https://www.crosstreecapital.com/
External link for Crosstree
- Industry
- Investment Banking
- Company size
- 11-50 employees
- Headquarters
- Tampa, FL
- Type
- Privately Held
- Founded
- 2004
- Specialties
- M&A, divestiture, recapitalization, buyout, equity, merger, acquisition, life sciences, health sciences, pharma services, pharma technology, healthcare it, digital health, and laboratory services
Locations
-
Primary
Get directions
5411 Skycenter Drive,
Suite 625
Tampa, FL 33607, US
Employees at Crosstree
Updates
-
Congratulations to Pinnacle Clinical Research, a portfolio company of LongueVue Capital, on its acquisition of Kerwin Medical Center to extend their therapeutic expertise into CNS and increase their geographic reach. To close our 133rd pharma services transaction, Crosstree helped Pinnacle identify Kerwin as the ideal partner through: 📈Evaluating a broad slate of potential strategic partners leveraging market expertise to identify the ideal transaction partner to drive future growth 💲Developing and articulating a strong value proposition which connected client capabilities with market trends to weave a compelling narrative for potential partners 🕘Streamlined deal funnel and managed the outreach process for organized and timely execution Read the full Deal Insights here: https://hubs.li/Q02FKvKV0 #pharma #pharmaceuticalindustry #mergersandacquisitions #investmentbanking Jason Layton Michael Levin
-
-
Today, we proudly celebrate America's 248th birthday! At Crosstree, we extend our heartfelt wishes for a safe and joyous Independence Day filled with cherished moments among friends and family. Happy Fourth of July! #4thofJuly #IndependenceDay
-
-
#NowHiring an Associate to join our team! We are looking for an investment banking professional to work with us within the diagnostics & tools space. This person should have 3-4 years of strong M&A experience, and is ready to hit the ground running in an exciting, fast-paced environment. Interested? Learn more and apply on the careers page of our website: https://hubs.li/Q02DrZkh0 #investmentbanking #lifesciences #bankingcareers #banking
-
-
Haemostasis / coagulation testing is used to monitor the ability of a patient’s blood to clot appropriately, which can determine the risk of excessive bleeding or developing clots (thrombosis). Amongst the various types of coagulation tests available, viscoelastic devices have experienced significant growth in recent years given their ability to run multiple tests simultaneously and provide a full coagulation profile in point-of-care settings. IBEX Technologies patented enzyme technologies and esteemed position in the In Vitro Diagnostics (IVD) industry made them the perfect partner for BBI Solutions to enhance their portfolio of recombinant proteins and broaden their North American presence. Crosstree acted as the exclusive financial advisor to BBI Solutions in this transaction. Read more about this partnership in our Deal Insights: https://hubs.li/Q02D1Rf10 #strategyconsulting #diagnostics #mergersandacquisitions #diagnosticmedicine Michael Levin
-
-
Catch up on the latest insights with our Diagnostics and Tools BlueBook, designed to provide valuable perspectives for industry leaders and private equity professionals. Discover a monthly executive review that captures the essence of valuation trends, M&A developments, and transactions. Key highlights from the May 2024 edition include: 📌Invitae was acquired by Labcorp 📌 Quest Diagnostics announced its acquisition of PathAI 📌 Karius, Inc. closed a $100MM Series A Financing, led by General Catalyst Group Management, LLC, 5AM Venture Management, LLC, Seventure Partners, Khosla Ventures, LLC, Innovation Endeavors LLC, HBM Healthcare Investments (Cayman) Ltd., Gilde Healthcare Partners US Inc, SoftBank Group Corp., Investment Arm, Waycross Ventures, Blue Water Life Science Advisors, LP Want to read more? Access the complete May 2024 edition here: https://hubs.li/Q02CFyN80 #InvestmentBanking #MergersAndAcquisitions #LifeSciences #PrivateEquity
-
-
The May 2024 edition of our Pharma Services: Drug Development BlueBook is now available. Read why C-suite executives and private equity professionals in the health sciences industries turn to our publication for valuation trends, M&A activity, and transaction reporting. Here's a glimpse into the May 2024 edition: 📌Blackstone Inc. (NYSE:BX) announced its acquisition of I'rom Group Co., Ltd. (TSE:2372) 📌Sift Medical Data, Inc. closed a $20MM Series A Financing, led by Allos Ventures, B Capital Group Management, L.P., First Trust Capital Partners LLC, Rock River Capital Partners Download the full May edition now: https://hubs.li/Q02CFCv90 #Insights #MergersAndAcquisitions #PrivateEquity #FinancialNews
-
-
Thank you to those who attended our executive reception on Monday during #DIA's Global Annual Meeting in San Diego! It was wonderful to meet some of you and reconnect with familiar faces while chatting about recent trends in pharma services. Interested in connecting with our team at the next industry trade show or reception? DM us, or email us at: marketing@crosstreecapital.com #DIA24 #DIAGlobalAnnualMeeting #investmentbanking #healthsciences #privateequity
-
-
Welcome to our Summer class of 2024! We are thrilled to welcome 6 full-time analysts, 9 Summer analysts, and our new Business Development Associate, Jordan Schiding, to the Crosstree team. We can’t wait to watch you all grow in your individual roles, and create new experiences and relationships as you continue your careers with our firm. Interested in joining the Crosstree team? View our open positions: https://hubs.li/Q02BL7L50 #internship #businessdevelopment #investmentbanking #bankingjobs
-
-
Are you attending #DIA2024 in San Diego? Join us for our invitation-only 11th annual Executive Industry Leaders Reception. There is no sales pitch and no agenda - simply an excellent opportunity to network with senior executives and private equity professionals that operating within the pharma services industry. Request an invitation: https://hubs.li/Q02B7Ntr0 #pharma #privateequity #pharmadevelopment Shane Senior Jason Layton Greg Bare Roger Christopher